BMC Evolutionary Biology 7, 78 (2007)
Some researchers inject GHK-Cu in the morning and Retatrutide on their designated weekly day regardless of timing
Injectable Epithalon Research into epithalon peptide therapy has primarily focused on two routes of administration: instranasal and injection (both subcutaneous and intramuscular)
Ultra-high purity (99.3%)
(The Demographics) Based on NPR investigation and online communities: Athletes (professional and amateur) Faster injury recovery Performance edge Willing to risk ban Biohackers and longevity seekers Anti-aging obsession "Optimize everything" mentality Follow influencers blindly Bodybuilders and fitness enthusiasts Muscle growth Fat loss Recovery between workouts People with chronic injuries Desperate for healing Failed conventional treatments Willing to try experimental options Gut health patients IBS, Crohn's, ulcerative colitis Leaky gut No FDA-approved options work Common thread: Desperation or optimization obsession, combined with aggressive online marketing
Who should not use it Its not the right choice for patients with: active cancer or a cancer history (stimulating cell growth signals can be harmful in these cases) active autoimmune conditions, where anything that affects the immune system carries additional risk pregnancy or breastfeeding significantly compromised liver or kidney function These arent minor caveats
